Tumor Infiltrating Lymphocytes - The Next Step in Assessing Outcome and Response to Treatment in Patients with Breast Cancer.
Tumor infiltrating lymphocytes are studied for their potential as new clinically useful prognostic and predictive biomarkers in patients with triple negative and HER-2/neu amplified breast cancer. This area of research could also help guide the development of novel therapeutic approaches for these diseases.
Center of Internal Medicine, Division of Medical Oncology, Ohio State University, Columbus, USA.
Robert
R
Wesolowski
Department of Surgical Oncology; OSU Comprehensive Cancer Center, Ohio State University, Columbus, USA.
William E
WE
Carson
Biomarkers; Breast cancer; Tumor infiltrating lymphocytes